TY - JOUR
T1 - Sequential purification of human apolipoprotein B-100, albumin, and fibrinogen by immunoaffinity chromatography for measurement of protein synthesis
AU - Fu, Ai zhong
AU - Morris, John C.
AU - Ford, G. C.
AU - Nair, K. Sreekumaran
N1 - Funding Information:
The authors acknowledge with gratitude the skillful support of Mai Persson and Carole Berg of the Biomedical Mass Spectrometry Laboratory of the GCRC, Mayo Clinic, for the mass spectrometric analysis; Elizabeth Bergert of the Endocrine Research Laboratory, Mayo Clinic, for her help with setting up the ELISA; and Thomas Beito for his help with preparation and production of monoclonal antibodies. The work was supported by Public Health Grant NIH RO DK41973 and GCRC Grant MO RR00585.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1997/5/1
Y1 - 1997/5/1
N2 - A determinant of the accuracy of protein synthesis measurement using stable isotope is the purity of the protein under study. An Immunoaffinity chromatographic technique to sequentially purify human plasma albumin, fibrinogen, and apolipoprotein B-100 (ApoB-100) was developed to measure isotopic enrichment in these proteins. The technique, utilizing immobilized mouse monoclonal antibodies specific to human plasma ApoB-100, albumin, and fibrinogen onto an affinity matrix, allowed purification of very low density lipoprotein (VLDL) ApoB-100, albumin, and fibrinogen from 1- to 2-ml plasma samples. Analytical sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by silver staining demonstrated consistent purity of the three purified proteins. The identity and the purity of the proteins separated by this technique were also confirmed by amino acid sequence analysis. This technique was applied to sequentially purify and measure the isotopic enrichment in those proteins by mass spectrometry from human plasma samples collected after orally ingesting L[1-13C]-leucine. Reproducibility of the enrichment measurements is within 5% of the coefficient of variation. Measurements [13C]leucine in these proteins purified from plasma samples collected during a 10-h primed continuous intravenous infusion of L-[1- 13C]leucine confirmed that this technique provides an efficient way to purify plasma VLDL ApoB-100, albumin, and fibrinogen for measuring their synthetic rates in human metabolism studies.
AB - A determinant of the accuracy of protein synthesis measurement using stable isotope is the purity of the protein under study. An Immunoaffinity chromatographic technique to sequentially purify human plasma albumin, fibrinogen, and apolipoprotein B-100 (ApoB-100) was developed to measure isotopic enrichment in these proteins. The technique, utilizing immobilized mouse monoclonal antibodies specific to human plasma ApoB-100, albumin, and fibrinogen onto an affinity matrix, allowed purification of very low density lipoprotein (VLDL) ApoB-100, albumin, and fibrinogen from 1- to 2-ml plasma samples. Analytical sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by silver staining demonstrated consistent purity of the three purified proteins. The identity and the purity of the proteins separated by this technique were also confirmed by amino acid sequence analysis. This technique was applied to sequentially purify and measure the isotopic enrichment in those proteins by mass spectrometry from human plasma samples collected after orally ingesting L[1-13C]-leucine. Reproducibility of the enrichment measurements is within 5% of the coefficient of variation. Measurements [13C]leucine in these proteins purified from plasma samples collected during a 10-h primed continuous intravenous infusion of L-[1- 13C]leucine confirmed that this technique provides an efficient way to purify plasma VLDL ApoB-100, albumin, and fibrinogen for measuring their synthetic rates in human metabolism studies.
UR - http://www.scopus.com/inward/record.url?scp=0031149094&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031149094&partnerID=8YFLogxK
U2 - 10.1006/abio.1997.2086
DO - 10.1006/abio.1997.2086
M3 - Article
C2 - 9177682
AN - SCOPUS:0031149094
SN - 0003-2697
VL - 247
SP - 228
EP - 236
JO - Analytical Biochemistry
JF - Analytical Biochemistry
IS - 2
ER -